Scientists for Science
Scientists for Science are confident that biomedical research on potentially dangerous pathogens can be performed safely and is essential for a comprehensive understanding of microbial disease pathogenesis, prevention and treatment. The results of such research are often unanticipated and accrue over time; therefore, risk-benefit analyses are difficult to assess accurately.
If we expect to continue to improve our understanding of how microorganisms cause disease we cannot avoid working with potentially dangerous pathogens. In recognition of this need, significant resources have been invested globally to build and operate BSL-3 and BSL-4 facilities, and to mitigate risk in a variety of ways, involving regulatory requirements, facility engineering and training. Ensuring that these facilities operate safely and are staffed effectively so that risk is minimized is our most important line of defense, as opposed to limiting the types of experiments that are done.
In contrast to recombinant DNA research at the time of Asilomar in 1975, studies on dangerous pathogens are already subject to extensive regulations. In addition to regulations associated with Select Agent research, experimental plans on other pathogens are peer reviewed by scientists and funding agencies, and the associated risk assessments are considered by biosafety experts and safety committees. Risk mitigation plans are proposed and then considered and either approved or improved by safety committees.
If there is going to be further discussion about these issues, we must have input from outside experts with the background and skills to conduct actual risk assessments based on specific experiments and existing laboratories. Such conversations are best facilitated under the auspices of a neutral party, such as the International Union of Microbiological Societies or the American Society for Microbiology, or national academies, such as the National Academy of Sciences, USA. We suggest they should organize a meeting to discuss these issues.
Scientists for Science have a range of opinions on how risk is best assessed. However, maintaining dogmatic positions serves no good purpose; only by engaging in open constructive debate can we learn from one another’s experience. Most importantly, we are united as experts committed to ensuring public health is not compromised and the reputation of science in general, and microbiology in particular, is defended.
We will use this forum to provide both scientists and the general public accurate information and to foster open and unbiased discourse on how to address these important contemporary issues in microbiology.
Founding Scientists
- Raul Andino, University of California, San Francisco
- Wendy Barclay, Imperial College London
- Constance Cepko, Harvard University
- Terence Dermody, Vanderbilt University
- Dickson Despommier, Columbia University
- Christian Drosten, University of Bonn Medical Centre
- Peter Doherty, University of Melbourne
- Paul Duprex, Boston University
- Rebecca Dutch, University of Kentucky
- Richard Elliott, University of Glasgow
- Mary Estes, Baylor College of Medicine
- Matthew Evans, Icahn School of Medicine at Mt. Sinai
- Ron Fouchier, Erasmus Medical Center
- Adolfo Garcia-Sastre, Icahn School of Medicine at Mt. Sinai
- Elodie Ghedin, New York University
- Yoshihiro Kawaoka, University of Wisconsin
- Wyndham W. Lathem, Northwestern University Feinberg School of Medicine
- Karla Kirkegaard, Stanford University
- Elke Muhlberger, Boston University
- Peter Palese, Icahn School of Medicine at Mt. Sinai
- Ann Palmenberg, University of Wisconsin
- Andrew Pekosz, Johns Hopkins University
- Julie Pfeiffer, University of Texas Southwestern Medical Center
- Glenn Rall, Fox Chase Cancer Center
- Vincent Racaniello, Columbia University
- Charles Rice, Rockefeller University
- Erica Ollmann Saphire, The Scripps Research Institute
- Stacey Schultz-Cherry, St. Jude Childrens Research Hospital
- Bert Semler, University of California, Irvine
- Peter Sarnow, Stanford University
- Michael Schmidt, Medical University of South Carolina
- Saul Silverstein, Columbia University
- Derek Smith, University of Cambridge
- Geoffrey Smith, University of Cambridge
- Benjamin tenOever, Icahn School of Medicine at Mt. Sinai
- Sean Whelan, Harvard University
- Harald zur Hausen, German Cancer Research Center
Supporting Scientists
- Randy A. Albrecht, Ichan School of Medicine at Mt. Sinai
- Matthew Aliota, University of Wisconsin-Madison
- Veaney Arteaga, Universidad Autónoma de Santo Domingo
- Justin Bahl, University of Texas Health Science Center at Houston
- J. Rhadamés Cabrera Balcácer, Xalapa Health Service
- Amiya Banerjee, Cleveland Clinic, Case Western Reserve University
- Prady Baviskar, St. Jude Children's Research Hospital
- Alan Belicha, Icahn School of Medicine at Mt. Sinai
- Eric Bergeron*, Centers for Disease Control and Prevention
- Kristen Bernard, University of Wisconsin-Madison
- Germar Beukes, University of the Witwatersrand
- Michele Bialecki, Cornell University
- Meyer Bjoern, University of St. Andrews
- Gabriella Blohm, University of Florida
- Deena Blumenkrantz*, Johns Hopkins University
- Martino Bolognesi, University of Milano
- Kevin Bonham, Harvard Medical School
- Chris Brooke*, NIAID, NIH
- Alexis Brubaker, Cornell University
- David Burke, University of Cambridge
- Gabriel Byrne, University of California, Santa Cruz
- Patricia Campbell, Emory University
- Marco Caporale, Istituto Zooprofilattico A&M
- Ian Carter, Prince of Wales Hospital, Sydney
- Mauricio Comas-Garcia*, NCI, NIH
- Ronald Corley, Boston University
- Jacqueline Corry, The Ohio State University
- Linda Coughlan, University of Oxford
- Robert W Cross, University of Texas Medical Branch
- Megan Crumpler*, County of Riverside Department of Public Health
- Clyde Dapat, Tohoku University
- Jose de la Fuente, Oklahoma State University
- Eric Delwart, University of California, San Francisco
- Mark Denison, Vanderbilt University
- Pritesh Desai, University of Florida
- Patricia Devaux, Mayo Clinic
- Maren DeVries, Freie Universität, Berlin
- Ulrich Desselberger, University of Cambridge
- James DiCarlo, Boston University
- Laura Eckard, University of Wisconsin-Madison
- Philip Egert, Virginia Tech
- Michael Emerman, Fred Hutchinson Cancer Research Center
- William Ettinger, Gonzaga University
- David J Evans, University of Warwick
- John Fazakerley, The Pirbright Institute
- Rachel Fearns, Boston University
- Mariet Feltkamn, Leiden University Medical Center
- Brian Ferguson, University of Cambridge
- Leandro Fernández Garcia, Institute of Tropical Medicine "Pedro Kouri", Cuba
- Andrea Ferrero-Perez, University of Maryland
- Helmut Fickenscher, Christian Albrecht University of Kiel
- Cadhla Firth*, CSIRO Australian Health Laboratory
- Mike Flint*, Centers for Disease Control and Prevention
- Gudrun Freidl, Erasmus Medical Center, RIVM
- Natalia Frias-Staheli, The Rockefeller University
- Chad Fuller, Independent Consultant, Molecular Virology
- Cynthia Fuller, Henderson State University
- Lee M Gehrke, Harvard University
- Robert Geraghty, University of Minnesota
- Alex Goetz, Retired Scientist
- Max Golden, University of Wisconsin-Madison
- William Goldman, The University of North Carolina at Chapel Hill
- Josephine Golding, King's College London
- Stephen Goldstein, University of Pennsylvania
- Ana Gonzalez-Reiche, University of Maryland
- Alexander Gorbalenya, Leiden University Medical Center
- Anthony Griffiths, Texas Biomedical Research Institute
- Rahm Gummuluru, Boston University
- Chelsea Hagan, Georgia State University
- Ben Hale, MRC - University of Glasgow Centre for Virus Research
- Mark Harris, University of Leeds
- Zachary Harris, University of Utah
- Sander Herfst, Erasmus Medical Center
- Julian Hiscox, University of Liverpool
- Charles Hobbs, retired scientist
- Sam Hobbs, Seattle BioMed
- Kay Hofman, University of Cologne
- Margaret Hosie, University of Glasgow
- Hallie Hoskins, University of Oregon
- Jennifer Huddleston, Abilene Christian University
- Islam Hussein, Massachusetts Institute of Technology
- Jih-Ru Hwu, National Tsing Hua University
- Michael Imperiale, University of Michigan
- Cristina Jimenez-Ortigosa, Rutgers University
- Emma Job, VIB-UGent
- Dirk Jochmans, University of Leuven
- Thomas B Kepler, Boston University
- Ghazi Kayali, St. Jude Childrens Research Hospital
- Gerald T Keusch, Boston University
- Brian Kimble, University of Texas Medical Branch, Galveston
- Laura Knoll, University of Wisconsin-Madison
- Matt Koci, North Carolina State University
- Alain Kohl, MRC - University of Glasgow Centre for Virus Research
- Lisa Kronstad, Stanford University
- Robert M Krug, University of Texas at Austin
- Thijs Kuiken, Erasmus Medical Center
- David Kushner, Dickinson College
- Lars la Cour Poulsen, Oslo University Hospital
- Seema Lakdawala*, NIAID, NIH
- Kevin Lang, University of Minnesota
- Ryan A Langlois, University of Minnesota
- Jackline Joy Lasola, University of Maryland School of Medicine
- Scott P Layne, University of California, Los Angeles
- Jessica Levingston Mac Leod, Icahn School of Medicine at Mt. Sinai
- Victor Leyva, Icahn School of Medicine at Mt. Sinai
- Weizhong Li, University of Maryland, College Park
- Ian Lipkin, Columbia University
- Anice Lowen, Emory University
- Bin Lu*, Vivaldi Biosciences Inc
- Harmit Malik, Fred Hutchinson Cancer Research Center
- Bindumadhav Marathe, St. Jude Childrens Research Hospital
- Glenn Marsh, CSIRO Australian Animal Health Laboratory
- Theresa Marth*, NIH
- Carles Martinez-Romero, Icahn School of Medicine at Mt. Sinai
- Luis Martinez-Sobrido, University of Rochester
- David Morens*, NIAID, NIH
- Richard Mathilde, Erasmus Medical Center
- Kevin McIver, University of Maryland
- Rafale Medina, Pontificia Universidad Catolica de Chile
- Nacho Mena, Icahn School of Medicine at Mt. Sinai
- Nicholas Minster, George Mason University
- Joanna Morrell, University of Glasgow Centre for Virus Research
- Pablo Murcia, University of Glasgow Centre for Virus Research
- Venugopal Nair, Pribright Institute
- Emily Nelson, Boston University
- Timothy Newsome, University of Sydney
- Josh Newson, University of Melbourne
- Johan Neyts, University of Leuven
- Jesse Noar, North Carolina State University
- Christine Oshansky-Weilnau, St. Jude Childrens Research Hospital
- Michelle Ozbun, University of New Mexico
- Prasad Paradkar*, CSIRO Australian Health Laboratory
- John Parker, Cornell University
- Michael Patterson, University of Texas at Galveston
- Jacqui Pearce*, MSD Animal Health
- Janet Peterson, University of Maryland
- Ariel Pereda, Instituto Nacional de Tecnologia Agropecuaria INTA
- Daniel Perez, University of Maryland
- Christian Pfaller, Mayo Clinic
- Maria Piccone, University of Massachusetts Dartmouth
- Sam Porter, University of Maryland, College Park
- Matthew Quinn*, Oxford Immunotec
- Gloria Ramirez-Nieto, University of Colombia
- Juan Antonio Raygoza Garay, The Pennsylvania State University
- Michael Reese, University of Texas, Southwestern Medical Center
- Veronica Rezelj, University of Glasgow Centre for Virus Research
- Juergen Richt, Kansas State University
- Agustina Rimondi, Instituto de Virologia, INTA, Argentina
- Amy Rosenfeld, Columbia University
- Polly Roy, London School of Hygiene & Tropical Medicine
- Steven Rubin*, Food and Drug Administration
- Charles Russell, St. Jude Childrens Research Hospital
- Kylie Ryan*, Genova Diagnostics
- Maria Carla Saleh*, Institut Pasteur
- Jefferson Santos, University of Maryland at College Park
- Kimberly Schultz, Johns Hopkins University
- Martin Schwemmle, University Medical Center Freiburg
- Reed Shabman, J. Craig Venter Institute
- Radwa Sharaf, Harvard University
- Megan Shaw, Icahn School of Medicine at Mt. Sinai
- Barbara Sherry, North Carolina State University
- Susan Shwu-Chen, National Central University
- Eric Snijder, Leiden University Medical Center
- Alicia Solorzano, Rutgers University
- Erin Sorrell, George Washington University
- Eugenio Spencer, Universidad de Santiago de Chile
- Kenneth Stedman, Portland State University
- John Steel, Emory University
- Silke Stertz, University of Zürich
- Danilo Stipp, Universidade Federal da Paraiba
- Nicola Stonehouse, University of Leeds
- Kanta Subbarao*, NIAID, NIH
- Christopher Sullivan, University of Texas at Austin
- Mehul Suthar, Emory University
- Troy Sutton*, NIAID, NIH
- Deeksa Tare, National Institute of Virology, Pune
- Jeffery Taubenberger*, NIAID, NIH
- Volker Thiel, Institut für Virologie und Immunologie IVI
- Darcy Thompson, Massachusetts Institute of Techology
- Mark Tompkins, University of Georgia
- Kenneth Toson*, Biosource Cultures and Flavors Inc
- Chadene Tremaglio, Dana-Farber Cancer Institute
- Ion Tripa, Institute of Medical Virology, Zürich
- Ralph Tripp, University of Georgia
- Vadim Tsvetnitsky, International AIDS Vaccine Initiative
- Melissa Uccellini, Icahn School of Medicine at Mt. Sinai
- Martijn van Hemert, Leiden University Medical Center
- Frank van Kuppeveld, Utrecht University
- Mariana Varela, University of Glasgow
- Ana B. Gorini da Veiga, Universidade Federal de Ciências da Saúde de Porto Alegre – UFCSPA, Brazil
- Thomas Voss*, SRI International
- Taia Wang, Rockefeller University
- Dallas Weaver*, Scientific Hatcheries
- Friedemann Weber, Philipps-University Marburg
- Winkler Weinberg, Kaiser Permanente
- Susan Weiss, University of Pennsylvania
- David Wentworth*, Centers for Disease Control and Prevention
- Lee M Wetzler, Boston University
- David M White*, National Centers for Animal Health, USDA
- Michael Wilson, University of California, San Francisco
- Sam Wilson, University of Glasgow Centre for Virus Research
- George Winter, University of Bristol
- Sebastian Winter, University of Texas Southwestern Medical Center
- Christiane Wobus, University of Michigan Medical School
- Sook San Wong, St. Jude Childrens Research Hospital
- James Wood, University of Cambridge
- Jon Yewdell*, NIAID, NIH
*signing as private individuals
Public Supporters
- Jessica A. Avizinis
- David Baker
- John Gilkenson
- Michael Lange
- Peter Smith